BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18534624)

  • 21. GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies.
    Hosoi Y; Suzuki-Sakao M; Terada T; Konishi T; Ouchi Y; Miyajima H; Kono S
    J Neurol; 2013 Dec; 260(12):3086-92. PubMed ID: 24091766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinico-pathological findings in a patient with progressive cerebellar ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and anti-GAD autoantibodies.
    Piccolo G; Tavazzi E; Cavallaro T; Romani A; Scelsi R; Martino G
    J Neurol Sci; 2010 Mar; 290(1-2):148-9. PubMed ID: 20056249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutamic acid decarboxylase autoantibodies and neurological disorders.
    Vianello M; Tavolato B; Giometto B
    Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunocytochemical and autoradiographic methods to demonstrate the coexistence of neuroactive substance: cerebellar Purkinje cells have glutamic acid decarboxylase, cysteine sulfinic acid decarboxylase, and motilin immunoreactivity.
    Chan-Palay V
    Acta Morphol Hung; 1983; 31(1-3):193-212. PubMed ID: 6312771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies.
    Vianello M; Bisson G; Dal Maschio M; Vassanelli S; Girardi S; Mucignat C; Fountzoulas K; Giometto B
    Autoimmunity; 2008 Feb; 41(1):66-73. PubMed ID: 18176866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.
    Markakis I; Alexiou E; Xifaras M; Gekas G; Rombos A
    Clin Neurol Neurosurg; 2008 Jun; 110(6):619-21. PubMed ID: 18433986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of hyperthermia-induced depression of GABAergic synaptic transmission in the immature rat hippocampus.
    Qu L; Leung LS
    J Neurochem; 2008 Sep; 106(5):2158-69. PubMed ID: 18643787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-localization of glycine and gaba immunoreactivity in interneurons in Macaca monkey cerebellar cortex.
    Crook J; Hendrickson A; Robinson FR
    Neuroscience; 2006 Sep; 141(4):1951-9. PubMed ID: 16784818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
    Bonnan M; Cabre P; Olindo S; Signate A; Saint-Vil M; Smadja D
    Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamate alteration of glutamic acid decarboxylase (GAD) in GABAergic neurons: the role of cysteine proteases.
    Monnerie H; Le Roux PD
    Exp Neurol; 2008 Sep; 213(1):145-53. PubMed ID: 18599042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GABA(B) receptor activation mediates frequency-dependent plasticity of developing GABAergic synapses.
    Xu C; Zhao MX; Poo MM; Zhang XH
    Nat Neurosci; 2008 Dec; 11(12):1410-8. PubMed ID: 18953347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GABA and synaptic inhibition of mouse cerebellum lacking glutamate decarboxylase 67.
    Obata K; Hirono M; Kume N; Kawaguchi Y; Itohara S; Yanagawa Y
    Biochem Biophys Res Commun; 2008 Jun; 370(3):429-33. PubMed ID: 18384748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia.
    Ishida K; Mitoma H; Wada Y; Oka T; Shibahara J; Saito Y; Murayama S; Mizusawa H
    J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):190-2. PubMed ID: 17119008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peculiar labeling of cultured hippocampal neurons by different sera harboring anti-glutamic acid decarboxylase autoantibodies (GAD-Ab).
    Vianello M; Giometto B; Vassanelli S; Canato M; Betterle C; Mucignat C
    Exp Neurol; 2006 Dec; 202(2):514-8. PubMed ID: 16890938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 17beta-estradiol affects GABAergic transmission in developing hippocampus.
    Wójtowicz T; Lebida K; Mozrzymas JW
    Brain Res; 2008 Nov; 1241():7-17. PubMed ID: 18822277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-GAD Antibodies and the Cerebellum: Where Do We Stand?
    Manto M; Mitoma H; Hampe CS
    Cerebellum; 2019 Apr; 18(2):153-156. PubMed ID: 30343467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of GABA transporter 3 in GABAergic synaptic transmission at striatal output neurons.
    Kirmse K; Kirischuk S; Grantyn R
    Synapse; 2009 Oct; 63(10):921-9. PubMed ID: 19588470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies.
    Vianello M; Tavolato B; Armani M; Giometto B
    Cerebellum; 2003; 2(1):77-9. PubMed ID: 12882238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory cerebellar circuits: GAD immunoreactivity in the frog cerebellum.
    Scherini E; Valli P; Fasolo A; Bernocchi G
    Neuroreport; 1990; 1(3-4):250-2. PubMed ID: 1966608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
    Honnorat J; Saiz A; Giometto B; Vincent A; Brieva L; de Andres C; Maestre J; Fabien N; Vighetto A; Casamitjana R; Thivolet C; Tavolato B; Antoine J; Trouillas P; Graus F
    Arch Neurol; 2001 Feb; 58(2):225-30. PubMed ID: 11176960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.